Company Profile

Novasterilis Inc
Profile last edited on: 11/14/2022      CAGE: 46VP8      UEI: HZMPWKV873R2

Business Identifier: Sterilization with supercritical carbon dioxide
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3109 North Triphammer Road
Lansing, NY 14882
   (607) 330-2772
Location: Single
Congr. District: 19
County: Tompkins

Public Profile

NovaSterilis, Inc., a biotechnology company, is organized around development and commercialization of supercritical carbon dioxide (SCCO2) technology for biomedical applications. Sterilization using supercritical carbon dioxide (SCCO2) involves lower temperatures (31°C) and pressure above 1100 psi. This lower temperature makes SCCO2 ideal for materials which are temperature sensitive or reactive with other forms of sterilization. The company offers NOVA 2200, a SCCO2 sterilizer, which is used to sterilize various types of allograft and engineered tissues, including skin, ligament, tendon, and bone without damage to the products structural or chemical integrity, and achieves Sterility Assurance Level of 10-6 (SAL6).

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  David C Burns -- President

  Timothy W Christensen

  Renee Christopher

  Josh Colistra -- VP of Sales and Marketing

  Julien Fey

  Julien Fey -- Director of R&D

  Janet L Huie

  Barbara Policay -- Manager, Business Operations

  Penny T Starkey

  Thomas Steffie -- VP of Business Development

  Aaron D Strickland